Disclosure Statement: Multiple Sclerosis Comprehensive Update
All individuals in a position to control the content of this activity have been asked to disclose any relationship they have with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
The following planners, speakers, and content reviewers have reported relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated:
| NAME | COMPANY | RELATIONSHIP |
|---|---|---|
| Course Planners | ||
| Tanuja Chitnis, MD, MA, FAAN | Novartis | Advisory Board/Committee, Consultant |
| Sanofi | Advisory Board/Committee, Consultant | |
| Sanofi | Research Support | |
| Novartis | Research Support | |
| Octave | Research Support | |
| Roche Genentech | Consultant | |
| I-Mab Biopharma | Research Support | |
| Roche Genentech | Research Support | |
| Tiziana Life Sciences | Research Support, Consultant | |
| Maria Houtchens, MD, MSc | Biogen | Research Support, Consultant |
| Genzyme | Research Support | |
| Serono | Consultant | |
| Roche | Research Support, Advisory Board/Committee | |
| Novartis | Research Support | |
| Course Faculty | ||
| Rohit Bakshi, MD, MA | Bristol-Myers Squib | Consultant, Research Support |
| EMD Serono | Consultant, Research Support | |
| Novartis | Research Support | |
| Shamik Bhattacharyya, MD | Alexion Pharmaceuticals | Research Support |
| Sarah Conway, MD | Bristol Myers Squibb | Advisory Board/Committee |
| Horizon Therapeutics | Advisory Board/Committee | |
| Banner Life Sciences | Speaker | |
| EMD Serono | Advisory Board/Committee | |
| Genentech | Advisory Board/Committee | |
| Laura Cox, PhD | Anaerobe Systems | Advisory Board/Committee |
| Kristin Galetta, MD, MSEd | GlaxoSmithKline | Consultant |
| Tamara Kaplan, MD | Genentech | Advisory Board/Committee |
| EMD serono | Advisory Board/Committee | |
| Eric Klawiter, MD, MSc | Genentech | Consultant, Research Support |
| Abbvie | Research Support | |
| Biogen | Research Support | |
| TG Therapeutics | Advisory Board/Committee | |
| OM1 | Consultant | |
| Intellisphere | Speaker | |
| Michael Levy, MD, PhD | Alexion | Research Support, Consultant |
| Genetech | Consultant, Research Support | |
| Horizon | Consultant | |
| Horizon | Research Support | |
| UCB | Investigator | |
| Sanofi | Investigator | |
| Farrah Mateen, MD, PhD | Genentech | Research Support |
| EMD Serono | Research Support | |
| Biogen | Research Support | |
| Horizon Therapeutics | Advisory Board/Committee | |
| Marcelo Matiello, MD | Horizon Therapeutics | Advisory Board/Committee |
| Alexion | Advisory Board/Committee | |
| Christopher Severson, MD | Novartis | Advisory Board/Committee |
| Biogen | Advisory Board/Committee | |
| Roche/Genentech | Advisory Board/Committee | |
| Sanofi/Genzyme | Advisory Board/Committee | |
| Tarun Singhal, MD, MBBS | Novartis | Research Support |
| I-mab | Research Support | |
| Tiziana | Consultant | |
| Biohaven | Research Support | |
| Jonathan Zurawksi, MD | Novartis Pharmaceutical | Research Support |
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.